Welcome to the INA-RESPOND public website.
Current and expanding infectious disease profile in Indonesia warrants a sense of urgency and mandates that research be a priority to guide the management and prevention of disease to reduce morbidity and mortality. The purpose of Indonesia Research Partnership on Infectious Diseases (INA-RESPOND) is to bring together clinical and academic medical institutions to develop a robust collaborative infectious disease research network.
CRIPIK ALERT: SELECTED CONCEPTS Rina La Distia Nora, MD, PhD, SpM(K), Infection and Immunology Division, Ophthalmology Department, Faculty of Medicine, Universitas Indonesia/ Cipto Mangun Kusumo Hospital, Jakarta Evy Yunihastuti, MD, PhD, Internal Medicine Department, Faculty of Medicine, Universitas Indonesia/ Cipto Mangun Kusumo Hospital, Jakarta Silvita Fitri Riswari, dr., M.Kes, Infectious and Tropical Disesase Division,
CLINICAL RESEARCH PROTOCOL WRITING WORKSHOP (CRIPIK 2019) LATE-BREAKER SUBMISSION DEADLINE: JANUARY 8, 2019 at 11.59 P.M. WIB INA RESPOND invites late-breaker study concepts to be submitted for CRIPIK 2019, 11-15 February 2019, Holiday inn Kemayoran, Jakarta Please visit https://ina-respond.net/CRIPIK/ for submissions
Indonesia Research Partnership on Infectious Diseases (INA-RESPOND) is clinical research collaboration on infectious diseases between the National Institute of Health Research and Development (NIHRD), Ministry of Health of Indonesia and the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). We establish a network of infectious diseases research and build
Research activity begins with the development of a clinical protocol that provides a plan for the essential aspects of the proposed research. A good research protocol should define a clear question and approach to answer it and also contain enough information to provide a clear and complete, but not overly detailed, description of the study. However,
To collect standardized baseline and longitudinal data describing the course of HIV disease in antiretroviral-naive and treatment-experienced individuals to inform policy.
To identify the etiology of acute febrile illness cases and evaluate clinical manifestations and outcomes.
To determine the causes of community-acquired sepsis and severe sepsis in adults and pediatrics across Southeast Asia.
To estimate the proportion of MDR TB amongst treatment naïve new treatment naïve and previously treated cases.
